Compare BNTX & KB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BNTX | KB |
|---|---|---|
| Founded | 2008 | 2008 |
| Country | Germany | South Korea |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.8B | 31.3B |
| IPO Year | 2019 | N/A |
| Metric | BNTX | KB |
|---|---|---|
| Price | $99.22 | $87.50 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $137.40 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 100.4K |
| Earning Date | 11-03-2025 | 02-04-2026 |
| Dividend Yield | N/A | ★ 2.32% |
| EPS Growth | N/A | ★ 31.42 |
| EPS | N/A | ★ 10.70 |
| Revenue | $3,698,814,972.00 | ★ $10,599,662,483.00 |
| Revenue This Year | $2.03 | $17.52 |
| Revenue Next Year | N/A | $2.13 |
| P/E Ratio | ★ N/A | $7.81 |
| Revenue Growth | 3.70 | ★ 5.94 |
| 52 Week Low | $81.20 | $46.38 |
| 52 Week High | $129.27 | $92.39 |
| Indicator | BNTX | KB |
|---|---|---|
| Relative Strength Index (RSI) | 61.03 | 48.29 |
| Support Level | $95.85 | $85.48 |
| Resistance Level | $95.71 | $89.44 |
| Average True Range (ATR) | 1.74 | 1.17 |
| MACD | 0.89 | 0.03 |
| Stochastic Oscillator | 98.14 | 32.02 |
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
KB Financial Group Inc. is a financial holding company in Korea. The company operations include Kookmin Bank, one of the commercial banks in Korea. The company's subsidiaries collectively engage in a broad range of businesses, including commercial banking, credit cards, asset management, non-life and life insurance, capital markets activities, and international banking and finance. The company's segments include the Banking business, Securities business, Non-life Insurance business, Credit card business, and Life Insurance business. The Group generates the majority of its revenue from the Banking business.